1)Mochizuki M et al:Epidemiology and clinical features of intraocular lymphoma. Ocul Immunol Inflamm 17:69-72, 2009
2)Kimura K et al:Clinical features and diagnostic significance of the intraocular fluid of 217 patients with intraocular lymphoma. Jpn J Ophthalmol 56:383-389, 2012
3)Coupland SE et al:Primary intraocular lymphoma:a review of the clinical, histopathological and molecular biological features. Graefes Arch Clin Exp Ophthalmol 242:901-913, 2004
4)Isobe K et al:Treatment of primary intraocular lymphoma with radiation therapy:a multi-institutional survey in Japan. Leuk Lymphoma 47:1800-1805, 2006
5)Kaburaki T et al:Combined intravitreal methotrexate and immunochemotherapy followed by reduced-dose whole-brain radiotherapy for newly diagnosed B-cell primary intraocular lymphoma. Br J Haematol 179:246-255, 2017
6)Frenkel S et al:Intravitreal methotrexate for treating vitreoretinal lymphoma:10 years of experience. Br J Ophthalmol 92:383-388, 2008
7)Habot-Wilner Z et al:Efficacy and safety of intravitreal methotrexate for vitreo-retinal lymphoma- 20 years of experience. Br J Haematol 194:92-100, 2021
8)Batchelor TT et al:High-dose methotrexate for intraocular lymphoma. Clin Cancer Res 9:711-715, 2003
9)Shah GD et al:Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma. J Clin Oncol 25:4730-4735, 2007
10)Cheah CY et al:Intensive chemoimmunotherapy and bilateral globe irradiation as initial therapy for primary intraocular lymphoma. Neuro Oncol 18:575-581, 2016
11)Hashida N et al:Association between ocular findings and preventive therapy with onset of central nervous system involvement in patients with primary vitreoretinal lymphoma. Graefes Arch Clin Exp Ophthalmol 252:687-693, 2014
12)Ma WL et al:Clinical outcomes of primary intraocular lymphoma patients treated with front-line systemic high-dose methotrexate and intravitreal methotrexate injection. Ann Hematol 95:593-601, 2016